Host: |
Rabbit |
Applications: |
WB/ELISA |
Reactivity: |
Human/Rat/Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-Hemoglobin subunit alpha (30-110 aa) is suitable for use in Western Blot and ELISA research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% Glycerol and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
WB 1:500-2000ELISA 1:5000-20000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
HBA1.HBA2 |
Gene ID: |
3039/3040 |
Uniprot ID: |
HBA_HUMAN |
Immunogen Region: |
30-110 aa |
Specificity: |
HBA Polyclonal Antibody detects endogenous levels of protein. |
Immunogen: |
Synthesized peptide derived from the human protein at the amino acid range 30-110 |
Post Translational Modifications | The initiator Met is not cleaved in variant Thionville and is acetylated. |
Function | Involved in oxygen transport from the lung to the various peripheral tissues. Hemopressin: Hemopressin acts as an antagonist peptide of the cannabinoid receptor CNR1. Hemopressin-binding efficiently blocks cannabinoid receptor CNR1 and subsequent signaling. |
Protein Name | Hemoglobin Subunit AlphaAlpha-GlobinHemoglobin Alpha Chain Cleaved Into - Hemopressin |
Database Links | Reactome: R-HSA-1237044Reactome: R-HSA-1247673Reactome: R-HSA-2168880Reactome: R-HSA-9707564Reactome: R-HSA-9707616 |
Alternative Antibody Names | Anti-Hemoglobin Subunit Alpha antibodyAnti-Alpha-Globin antibodyAnti-Hemoglobin Alpha Chain Cleaved Into - Hemopressin antibodyAnti-HBA1.HBA2 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance